Germany’s Merck KGaA pledged $1.3 billion to a pair of AI agreements with Exscientia and BenevolentAI aimed at the development of drugs in oncology, neurology, and immunology. Valo Health is ...
Valo takes a human-centric approach to AI, CEO Brian Alexander said in an ... can leverage Opal and make a significant impact on human health. However, OPL-0401, a diabetic retinopathy drug ...
Novo Nordisk and Valo Health have expanded their 16-month-old collaboration into an up-to-$4.6 billion-plus artificial intelligence (AI) partnership aimed at discovering and developing up to 20 ...
Jan 8 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab and U.S. tech firm Valo Health said on Wednesday ... and artificial intelligence (AI). Last month Novo's drug candidate ...
Novo Nordisk is doubling down on its collaboration with Valo Health, committing up to $190 ... a Flagship Pioneering company with big ambitions for AI, in 2023. That deal was worth $60 million ...
About Valo Health Valo Health, Inc is leveraging artificial intelligence (AI) and advanced analytics to better learn from the patient experience to discover and develop better medicines at greater ...
Novo Nordisk Expands AI Partnership With Valo Health for Development of Obesity Drugs (Reuters) - Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback